South Korea’s NIH and CDC, Affymetrix, Agilent Technologies, Signature Genomic Laboratories, 23andMe, Parkinson’s Institute and Clinical Center, Witec, Fluidigm, Tecan | GenomeWeb
South Korea's NIH Expands Human Disease Study with Affy Microarray Buy
South Korea’s National Institute of Health and Center for Disease Control and Prevention plans to use Affymetrix’s Genome-Wide Human SNP Array 6.0 as it expands the Korean Association Resource project (KARE), which is focused on discovering genes that are associated with lifestyle-related complex disorders, Affy said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.